Investment Summary

Eventi Capital Partners Invests In Visualase

On February 1, 2009, growth capital firm Eventi Capital Partners invested in medical products company Visualase

Investment Highlights
  • This is Eventi Capital Partners’ 1st transaction in the Medical Products sector.
  • This is Eventi Capital Partners’ 1st transaction in the United States.
  • This is Eventi Capital Partners’ 1st transaction in Texas.
Investment Fate
  • Visualase was divested to a consortium of buyers in 2014 for 105M USD.

Investment Summary

Date 2009-02-01
Target Visualase
Sector Medical Products
Investor(s) Eventi Capital Partners
Deal Type Growth Capital

Target

Visualase

Houston, Texas, United States
Visualase, Inc. is a developer and marketer of an FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgeries, including surgical thermal ablation.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

Eventi Capital Partners is a private investment group focused on growth capital investments in SaaS based businesses, internet infrastructure, and medical devices. Eventi was formed in 2002 and is based in Toronto, Ontario.


DEAL STATS #
Overall 3 of 6
Sector (Medical Products) 1 of 1
Type (Growth Capital) 2 of 4
State (Texas) 1 of 2
Country (United States) 1 of 2
Year (2009) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-03-11 Thindata

Toronto, Ontario, Canada

Thindata is a multi-channel database-driven marketing automation technologies and strategic solutions company. The company helps to systematically move customer communications from outmoded mass marketing to compelling and effective 1:1 dialogue communications – thereby maximizing your revenue growth and ROI.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-28 Visualase

Houston, Texas, United States

Visualase, Inc. is a developer and marketer of an FDA-approved MRI-guided laser and image guided system for minimally invasive neurosurgeries, including surgical thermal ablation.

Sell $105M